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ABSTRACT 
Liver is one of the most important organ, which plays a provital role in regulating various physiological processes in the body. It has gr eat 
capacity to detoxicate toxic substances and synthesize useful principles. Callicarpa macrophylla has witnessed pivotal role in herbal medicine 
since several years. The ethanolic & aqueous extracts of Callicarpa macrophylla leaves was tested for its phytochemical constituents and 
hepatoprotective activity against CCl4 induced hepatotoxicity in wistar rats. The results revealed that the oral administration of CCl4 (2 mL/kg) 
to the animals caused statistically significant (p<0.05) increases in the serum activities of SGOT, SGPT, ALP and bilirubin when compared with 
control group where there was decreased in level of total protein and albumin. The extract at a dose of200 & 400 mg/kg(for both extract) was 
able to protect against CCl4 induced hepatotoxicity in albino rat as revealed by significant decreases in the serum level of SGOT, SGPT, ALP and 
bilirubin and whereas an increase in total protein concentration when compared to the CCl4+distilled water treated group. The ethanolic 
extract at 400mg/kg, p.o. was found most effective among all the extract treatments when compared to CCl4+distilled water treated groups. The 
further studies are needed to evaluate potential usefulness of ethanolic and aqueous extract in clinical condition associated with liver damage. 
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INTRODUCTION 
The liver is the largest gland of the body playing an 
astonishing array of vital functions in the continuation, 
performance and adaptable homeostasis of the body. It is 
concerned with approximately all the biochemical pathway 
to enlargement, fight in opposition to disease, nutrient 
contribute, energy stipulation and reproduction [1-2]. Liver 
disease is one of the major causes of morbidity and mortality 
in public which affects humans of all ages. Due to liver 
disease about 20,000 deaths occur every year [3-5]. Some of 
the commonly known disorders of liver are viral hepatitis, 
alcohol liver disease, non-alcoholic fatty liver disease, 
autoimmune liver disease, metabolic liver disease, drug 
induced liver injury, gallstones etc. 
Hepatocellular carcinoma is one of the ten most common 
tumour in the world with over 2, 50,000 new cases each year 
[3]. Cell damage is caused by free radicals through 
mechanisms of covalent binding and lipid peroxidation with 
subsequent tissue injury. Some synthetic compounds are 
currently available as hepatoprotective agents. However, 
such compounds may exert several side effect and 
disadvantages. In view of severe adverse side effects of 
synthetic agents, there is growing focus to develop more 
valuable and protected drugs which may raise the 
therapeutic benefits for patients [3-5]. Numerous medicinal 
plants and their formulations are used for liver disorders in 
ethno medical practices as well as in traditional systems of 
medicine in India [7]. 
Liver is involved in several vital functions, such as 
metabolism, secretion and storage and it is the most 
important organ, which plays a provital role in regulating 
various physiological processes in the body. It has great 
capacity to detoxicate toxic substances and synthesize useful 
principles. Liver functions as a center of metabolism of 
nutrients such as carbohydrates, proteins and lipids and 
excretion of waste metabolites. Additionally, it also handles 
the metabolism and excretion of drugs and other xenobiotics 
from the body thereby providing protection against foreign 
substances by detoxifying and eliminating them [9-10]. Liver 
cells possess the antioxidant defence system consisting of 
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antioxidants such as growth stimulating harmone (GSH), 
ascorbic acid, vitamin E and antioxidant enzymes such as 
superoxide dismutase (SOD), catalase and GPx to protect 
own cells against oxidative stress, which causes destruction 
of cell components and cell death. The liver is a major target 
organ for toxicity of xenobiotics and drugs, because most of 
the orally ingested chemicals and drugs first go to liver 
where they are metabolized into toxic intermediates. 
A large number of xenobiotics are reported to be potentially 
hepatotoxic, Hepatocytes, which make up the majority of the 
liver structure, are very active in the metabolism of 
exogenous chemicals, and this is one of the major reasons 
why the liver is a target for toxic substances. During the 
detoxification of xenobiotics, reactive oxygen species (ROS) 
are generated which cause oxidative stress which leads to 
the hepatic damage. 
Hepatotoxicity is a damage or injury to liver which is caused 
by various drugs, chemicals and other agents. Extent of liver 
damage or injury depends on degree of exposure, mild liver 
damage cause dysfunctioning but severe liver damage result 
in liver failure. The liver is largest organ in a body weighing 
about 1.4-1.6 kg in the males and 1.2-1.4 kg in the females. 
The liver receives a dual blood supply with about 20% of 
blood coming from the hepatic artery and 80% from the 
portal circulation. The blood flow to the liver is around 20 to 
25% of the total cardiac output. It serves various vital 
functions. The most important function of liver is to filter 
toxic substances from the body, including alcohol and 
various medications like chemotherapy drugs such as 
antibiotics, acetaminophen etc.[11]. 
Liver damage is associated with cellular necrosis, increase in 
tissue lipid peroxidation and depletion in the tissue GSH 
levels. In addition serum levels of many biochemical 
markers like SGOT, SGPT, triglycerides, cholesterol, bilirubin, 
alkaline phosphatase are elevated [12].Liver disease is one 
of the major causes of morbidity and mortality in public, 
affecting humans of all ages. About 20,000 deaths occur 
every year due to liver disorders. Some of the commonly 
known disorders are viral hepatitis, alcohol liver disease, 
non-alcoholic fatty liver disease, autoimmune liver disease, 
metabolic liver disease, drug induced liver injury, gallstones, 
etc. Hepatocellular carcinoma is one of the ten most common 
tumors in the world with over 2,50,000 new cases each year 
[5, 13]. 
Biologic factors such as hepatitis virus, bile duct obstruction, 
cholesterol overload, schistosomiasis etc. or chemical factors 
such as CCl4 administration, alcohol intake, etc. were known 
to contribute to liver fibrosis. Hepatic fibrosis is major 
features of a wide range of chronic liver injuries including 
metabolic, viral, cholestatic and genetic disease. The failure 
of bile salt excretion in cholestasis leads to retention of 
hydrophobic bile salts within the hepatocytes and causes 
apoptosis and/or necrosis [14]. Oxidative stress has been 
implicated in the pathogenesis of various liver diseases 
including alcoholic liver disease, nonalcoholic fatty liver 
disease, and chronic hepatitis. In many patients, hepatitis 
such as non-alcoholic fatty liver disease becomes chronic 
and eventually progresses to more serious liver pathologies, 
such as fibrosis, cirrhosis, or even carcinogenesis, causing 
devastating economic losses and mortality [15]. Drug-
induced liver disease can be predictable (high incidence and 
dose-related) or unpredictable (low incidence and may or 
may not be dose-related). Unpredictable reactions, also 
referred to as idiosyncratic, can be viewed as either 
immune-mediated hypersensitivity or nonimmune 
reactions. Most potent predictable hepatotoxins are 
recognized in the animal testing or clinical phase of drug 
development. 
Hepatotoxicity and Its Mechanism 
Liver plays a central role in transforming and clearing 
chemicals and is consequently susceptible to the toxicity 
induced from these agents. Chemicals that cause liver injury 
are termed as hepatotoxins, and more than 900 drugs have 
been implicated in causing liver injury and it is the most 
common reason for a drug to be withdrawn from the market. 
Chemicals often cause subclinical injury to liver which may 
be manifest by abnormal liver enzyme tests. Certain 
medicinal agents when taken in overdoses and sometimes 
even when introduced within therapeutic ranges may injure 
the organ. Other chemical agents such as those used in 
laboratories and industries, natural chemicals (e.g. 
Microcystins) and herbal remedies can also induce 
hepatotoxicity (e.g. Lycopodium serratum and Ephedra 
equisetina). 
The unique property of liver to metabolize substances and 
its close relationship with the gastrointestinal tract, it is 
highly susceptible to injury from drugs and other 
substances. Approximately 75% of blood reaching the liver 
arrives directly from gastrointestinal organs and then spleen 
through portal veins which bring drugs and xenobiotics in 
concentrated form. Numerous mechanisms may be cited to 
be responsible for either inducing hepatic injury or 
worsening the damage process. Although exact mechanism 
of hepatic injury remains largely unknown, it appears to 
involve 2 pathways that is direct hepatotoxicity and adverse 
immune reactions.  
In most instances, hepatic injury is initiated by the 
bioactivation of drugs to chemically reactive metabolites, 
which have the ability to interact with cellular 
macromolecules such as proteins, lipids, and nucleic acids, 
leading to protein dysfunction, lipid peroxidation, DNA 
damage, and oxidative stress [16]. Additionally, these 
reactive metabolites may induce disruption of ionic 
gradients and intracellular calcium stores, resulting in 
mitochondrial dysfunction and loss of energy production. Its 
dysfunction releases excessive amount of oxidants which in 
turn injures hepatic cells. Activation of some enzymes in the 
cytochrome P-450 system such as CYP2E1 also leads to 
oxidative stress. Injury to hepatocyte and bile duct cells lead 
to accumulation of bile acid inside liver. This promotes 
further liver damage. This impairment of cellular function 
can culminate in cell death [17].  
Hepatic cellular dysfunction and death also have the ability 
to initiate immunological reactions, including both innate 
and adaptive immune responses. Stress and damage to 
hepatocytes result in the release of signals that stimulate 
activation of other cells, particularly those of the innate 
immune system, including Kupffer cells (KC), natural killer 
(NK) cells. These cells contribute to the progression of liver 
injury by producing proinflammatory mediators and 
secreting chemokines to further recruit inflammatory cells 
to the liver. It has been demonstrated that various 
inflammatory cytokines, such as tumor Necrosis factor 
(TNF)-α, Interferon (IFN)-γ, and Interleukin (IL)-1β, 
produced during hepatic injury are involved in promoting 
tissue damage [18]. However, innate immune cells are also 
the main source of IL-10, IL-6, and certain prostaglandins, all 
of which have been shown to play a hepatoprotective role 
[19]. Thus, it is the delicate balance of inflammatory and 
hepatoprotective mediators produced after activation of the 
innate immune system that determines an individual’s 
susceptibility and adaptation to hepatic injury. 
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Figure 1: Mechanism of hepatic injury 
Hepatoprotective Study  
Natural products and their active principles as sources for 
new drug discovery and treatment of diseases have attracted 
attention in recent years. Herbs are generally considered 
safe and proved to be effective against various human 
ailments. Herbal based therapeutics for liver disorders has 
been used in India for a long time and has been popularized 
in world over by leading pharmaceuticals [20]. The currently 
observed rapid increase in consumption of herbal remedies 
worldwide has been stimulated by several factors, including 
the notion that all herbal products are safe and effective. The 
21st century has seen a paradigm shift towards therapeutic 
evaluation of herbal products in liver disease models by 
carefully synergizing the strength of the traditional systems 
of medicine with that of the modern concept of evidence 
based medicinal evaluation, standardization and 
randomized placebo controlled clinical trials to support 
clinical efficacy [21]. 
Herbal drugs are more widely used than allopathic; drugs as 
hepatoprotective because of them are inexpensive, better 
cultural acceptability, better compatibility, with the human 
body and minimal side effects. These herbal drugs have 
shown the ability to maintain the normal functional statues 
of the liver with or without fewer side effects. The liver plays 
an astonishing array of vital functions in the maintenance, 
performance and regulating homeostasis of the body. It is 
involved with almost all the biochemical pathways to 
growth, fight against disease, nutrient supply, energy 
provision and reproduction. Therefore, maintenance of a 
healthy liver is essential for the overall well-being of an 
individual. Liver cell injury caused by various toxicants such 
as certain chemotherapeutic agents, carbon tetrachloride, 
thioacetamide etc. chronic alcohol consumption and 
microbes is well-studied. Among the many diseases that can 
affect the liver the most common is 'viral hepatitis' 
(Inflammation of liver caused by viral infection). Hepatitis 
can be caused by drugs, viruses, bacteria, mushrooms, 
parasites like amoebas or giardiasis.  
Herbal drugs have gained importance and popularity in 
recent years because of their safety, efficacy and cost 
effectiveness. Several Indian medicinal plants have been 
extensively used in the Indian traditional system of medicine 
for the management of liver disorder. The use of natural 
remedies for the treatment of liver diseases has a long 
history and medicinal plants and their derivatives are still 
used all over the world in one form or the other for this 
purpose. Scientific evaluation of plants has often shown that 
active principles in these are responsible for therapeutic 
success [22]. A large number of medicinal plants have been 
tested and found to contain active principles with curative 
properties against a variety of diseases. Liver protective 
plants contain a variety of chemical constituents like 
phenols, Coumarins, Lignans, essential oil,monoterpenes, 
carotinoids, glycosides, flavonoids, organic acids, lipids, 
alkaloids and xanthenes.  
Therefore a large number of plants and formulations have 
been claimed to have hepatoprotective activity so the 
development of plant based hepatic protective drugs has 
been given importance in the global market. This review 
article has been presented to enumerate some plants that 
have hepatoprotective properties such as 
Abelmoschusmoschatus, Ageratum conyzoide, 
Ardisiasolanacea, Arisaema leschenaultia, Callicarpa 
macrophylla, Capparisspinosa,Cassia auriculata, 
Chenopodium album, Chrysophyllumalbidum[23].  
MATERIALS AND METHODS 
To evaluate the hepatoprotective effect of Callicarpa 
macrophylla leavesextract against carbon tetrachloride 
induced hepatotoxicity in experimental rats, following 
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chemicals, reagents, diagnostic kits, equipments& 
instruments were used. All chemicals and reagents used 
were of analytical grade. 
Table 1: Chemicals, Reagents & Diagnostic kits. 
Chemical Name Company Name 
Carbon Tetrachloride 
GalaxoSmithkline 
Pharmaceutical Ltd. 
Liquid Paraffin RFCL Limited 
Ethanol SD -Fine Chemicals Limited 
Di-ethyl Ether SD- Fine Chemicals Limited 
Glycerine RFCL Limited 
Petroleum ether RFCL Limited 
Silymarin Asklepios Remedies (Pvt.) Ltd. 
Formaldehyde RFCL Limited 
SGOT  Diagnostic Kit Span Diagnostics Ltd. 
SGPT  Diagnostic Kit Span Diagnostics Ltd. 
ALP  Diagnostic Kit Span Diagnostics Ltd. 
Bilirubin Diagnostic Kit Span Diagnostics Ltd. 
Albumin Diagnostic Kits  Span Diagnostics Ltd. 
 
Extraction of Leaves 
Ethanolic Extract 
Coarsely powdered leaves (350gm) were extracted with 
Soxhlet apparatus using petroleum ether for about 12 hrs. 
After defatting the marc was air dried and packed into 
Soxhlet apparatus and further extracted with 95% ethanol. 
The solvent were removed from the extracts under reduced 
pressure by using rotator vacuum evaporator. The 
percentage yield of ethanolic extract was found to be 7.5%. 
Aqueous Extract  
Coarsely powdered leaves (350gm) was taken into a round 
bottom flask (200 mL) and macerated with into 500mL of 
distilled water and 10mL of chloroform (preservative) for 24 
h with occasional shaking for every hour. Then the marc was 
removed by filtering the extract and the extract was 
concentrated on a water bath maintained at 500C. The 
percentage yield of ethanolic extracts was found to be 6%. 
Experimental Animals 
Wistar rats of (180-200 gm) of either sex were obtained 
from animal house for evaluation of hepatoprotective effect 
of Callicarpa macrophylla against CCl4 induced hepatic injury 
in rats.Animal were kept at room temperature 23±2 ºC 
controlled humidity condition (50-55 %) and 12 hrs light 
and dark cycles. They were caged with a maximum of three 
animals in each polypropylene cage and were fed with 
standard food pellets and water.  
Acute Toxicity 
Acute toxicity was performed as per OECD guideline No.420. 
Female rats were dosed in a stepwise procedure using the 
fixed doses of aqueous and ethanolic extracts of Callicarpa 
macrophylla leaves5, 50, 300 and 2000 mg/kg and after 
dosing animals were observed for signs and conditions 
associated with pain, suffering, behavior and mortalityat 
first 30 minutes and every 4 hours periodically during the 
first 24 hours and daily thereafter for a total of 14 days.  
Induction of Hepatotoxicity 
Carbon tetrachloride (CCl4) was used for inducing 
hepatotoxicity. Liver damage was induced in rat with 1:1 
(v/v) mixture of CCl4 in liquid paraffin, administered intra- 
peritoneal at a dose of 2 mL/ kg on 9th day of the study. 
 
Experimental Design for Hepatoprotective Activity 
Animals were randomly divided into seven groups of six 
animals each and treated orally, once daily for nine days in 
the following manner.Group I-served as normal control and 
received distilled water (5mL/kg).Group II-served as toxic 
control and received distilled water (5mL/kg) and 1:1 (v/v) 
mixture of CCl4 in liquid paraffin (2 mL/kg, i.p) on 9th day. 
Group III-served as standard group and received Silymarin 
(50 mg/kg) and 1:1 (v/v) mixture of CCl4 in liquid paraffin (2 
mL/kg, i.p) on 9th Day. Group IV was treated with ethanolic 
extract of Callicarpa macrophylla leaves (200 mg/kg/Day) 
and 1:1 (v/v) mixture of CCl4 in liquid paraffin (2 mL/kg, i.p) 
on 9th Day. Group V was treated with ethanolic extract of 
Callicarpa macrophylla leaves (400 mg/kg/Day) and 1:1 
(v/v) mixture of CCl4 in liquid paraffin (2 mL/kg, i.p) on 9th 
day.Group VI was treated with aqueous extract of Callicarpa 
macrophylla leaves (200 mg/kg, Day) and 1:1 (v/v) mixture 
of CCl4 in liquid paraffin (2mL/kg, i.p) on 9th Day. Group VII 
was treated with aqueous extract of Callicarpa macrophylla 
leaves (400 mg/kg, Day) and 1:1 (v/v) mixture of CCl4 in 
liquid paraffin (2 mL/kg, i.p) on 9th Day. 
Estimation of Liver Function Enzymes 
To determine the functional state of liver, after 24 hours of 
CCl4 administration (10th Day), blood samples were collected 
by retro-orbital plexus puncture under mild ether 
anesthesia. The collected blood was allowed to clot at room 
temperature and serum was separated by centrifugation at 
2500 rpm for 15 min. Then serum was used for the 
estimation of biochemical parameters such as serum 
glutamate oxaloacetate transaminase (SGOT), serum 
glutamate pyruvate transaminase (SGPT), alkaline 
phosphatase (ALP), serum total bilirubin (TB) and total 
protein (TP).The biochemical parameters were estimated as 
per the standard procedure prescribed by manufacturer’s 
instruction manual provided in the standard kit using 
autoanalyser. 
Estimation of Serum Glutamate Oxaloacetate 
Transaminase (SGOT)  
Method: 2, 4-DNPH (Reitman and Frankel Method) 
Principle:Aspartate aminotransferase (AST) catalysis the 
transamination of L- Aspartate and α- Ketoglutamate (α-KG) 
to form Oxaloacetate and L- Glutamate. Oxaloacetate so 
formed is coupled with 2, 4- Dinitrophenyl hydrazine (2, 4-
DNPH) to form a corresponding hydrazone, a brown colored 
complex in alkaline medium and this can be measured 
calorimetrically. 
α- KG + L- Aspartate                       Oxaloacetate + L- Glutamate  
Oxaloacetate+X2, 4- DNPH                                    
    Corresponding Hydrazone  
Reitman and Frankel Method is an end-point colorimetric 
method for the estimation of enzymes activity. To obtain 
accurate results, method has been standardized with Kinetic 
Method (Standard Karmen unit assay). This product is single 
point calibration version of original method for maximum 
ease of use and convenient. 
Reagents: 
S. No. Reagents 
1. Buffered Aspartate- α-KG Substrate, pH 7.4 
2. 2,4-DNPH Colour Reagent 
3. Sodium Hydroxide, 4N 
4. Working Pyruvate Standard, 6mM (114 IU/L) 
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Preparation of Working Reagent: 
Reagent 1, 2 and 4 were ready to use andsolution 1: Dilute 1mL of Reagent 3 to 10 mL with purified water. 
Procedure
 
 
Mix well and read the O.D (Optical Density) against purified water in a Colorimeter using green filter or on Photometer at 505 
nm, within 15 minutes.    
Calculation: 
AST (GPT) activity = Conc. of Standard 
 
Estimation of Serum Glutamate Pyruvate Transaminase 
(SGPT)  
Method: 2, 4-DNPH (Reitman and Frankel Method)  
Principle: Alanine aminotransferase (ALT) catalysis the 
transamination of L-Alanine and α- Ketoglutarate (α-KG) to 
form Pyruvate and L- Glutamate. Pyruvate so formed is 
coupled with 2, 4- Dinitrophenyl hydrazine (2, 4-DNPH) to 
form a corresponding hydrazone, a brown colored complex 
in alkaline medium and this can be measured 
calorimetrically.
 
α- KG + L- Alanine                                  Pyruvate + L- Glutamate 
Pyruvate + 2, 4- DNPH                                   Corresponding Hydrazone (Brown color) 
 
Reitman and Frankel Method is an end-point colorimetric 
method for the estimation of enzymes activity. To obtain 
accurate results, method has been standardized with Kinetic 
Method (Standard Karmen Unit Assay). This product is 
single point calibration version of original method for 
maximum ease of use and convenience. 
 
Reagents: 
 
 
 
 
Preparation of Working Reagent: 
Reagent 1, 2 and 4 were ready to use and solution 1: Dilute 1mL of Reagent 3 to 10 mL with purified water. 
Procedure: 
Mix well and read the O.D (Optical Density) against purified water in a Colorimeter using green filter or on Photometer at 505 
nm, within 15 minutes. 
Pipette into tube marked Blank Standard Test Control 
Reagent 1 0.25mL 0.25mL 0.25mL 0.25mL 
Serum - - 0.05mL - 
Standard - 0.05mL -  
Mix well and incubate at 370C for 60 minutes 
Reagent 0.25mL 0.25mL 0.25mL 0.25mL 
Deionised water 0.05mL - - - 
Serum - - - 0.05mL 
Mix well and allow to stand at Room Temperature (1500 -30 0C) for 20 minutes 
Solution 1 2.5mL 2.5mL 2.5mL 0.05mL 
S. No. Reagents 
1. Buffered Aspartate- α-KG Substrate, pH 7.4 
2. 2,4-DNPH Colour Reagent 
3. Sodium Hydroxide, 4N 
4. Working Pyruvate Standard, 8mM (150 IU/L) 
Pipette into tube marked Blank Standard Test Control 
Reagent 1 0.25mL 0.25mL 0.25mL 0.25mL 
Serum - - 0.05mL - 
Standard - 0.05mL -  
Mix well and incubate at 370C for 60 minutes 
Reagent 0.25mL 0.25mL 0.25mL 0.25mL 
Deionised water 0.05mL - - - 
Serum - - - 0.05mL 
Mix well and allow to stand at Room Temperature (1500 -30 0C) for 20 minutes 
Solution 1 2.5mL 2.5mL 2.5mL 0.05mL 
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Calculation: 
ALT (GPT) activity =  Conc of standard 
 
Estimation of Serum Alkaline Phosphatase (ALP)  
Method: Kind and King’s   
Principle: Alkaline Phosphatase from serum converts 
Phenyl Phosphate to Inorganic Phosphate and Phenol at pH 
10.0. Phenol so formed reacts in alkaline medium with 4-
Aminoantipyrine in presence of the oxidizing agent 
Potassium Ferricyanide and forms an Orange-Red colored 
complex, which can be measured colorimetrically. The color 
intensity is proportional to the enzyme activity. 
The Reaction can be represented as: 
 
Phenyl Phosphate            Phenol + Phosphate 
Phenol + 4-Aminoantipyrine         Orange-Red complex (λ max= 510-520 nm). 
Reagents: 
Reagent 1: Buffered Substrate, pH 10.0 
Reagent 2: Chromogen Reagent  
Reagent 3: Phenol Standard, 10 mg%  
Preparation of Working Reagent: 
Reconstitute one vial of Reagent 1, Buffered substrate with 2.2 mL of Purified Water. 
Reagents 2 and 3 were ready to use. 
Procedure: 
 
Mix well after addition of each Reagent and measure the O.D (Optical Density) of Blank (B), Standard (S), Control (C) and Test 
(T) against Purified Water using a Green filter.  
Calculation: 
Serum Alkaline Phosphate activity =  × 10 
 
Estimation of Serum Bilirubin (BIL)  
Method: Jendrassik and Grof Method. 
It was estimated by using commercially available standard 
kit supplied by Span Diagnostics Ltd. Surat (India). 
Principle: Both conjugated and unconjugated bilirubin 
reacts with diazotized sulphanilic acid. Reaction with 
unconjugated bilirubin is hastened by the use of caffeine 
sodium benzoate as accelerator for Serum Bilirubin 
estimation. The pink colour developed was measured at 540 
nm and the intensity of colour formed is directly 
proportional to bilirubin concentration in the sample. 
 
Reagents: 
Reagent 1: Nitrite Reagent; Sodium Nitrite 10mM 
Reagent 2: Sulphanilic acid; Suphanilic acid 26 mM and 
Hydrochloric acid 180 mM 
Reagent 3: Accelerator; Sodium Benzoate  340 mM and 
Caffeine 200 mM 
Assay Parameters 
Reaction Type - End Point, Reaction Time - 5 min. at R.T. 
, Wavelength -540 nm, Zero Setting with-Serum Blanks, 
Sample volume-0 50 μL, Reagent volume-1.02 mL, Factor-
20.2, Linearity-20 mg/dl
 
 
 
Pipette into marked Blank (B) Standard (S) Control (C) Test (T) 
Working buffered 0.5mL 0.5mL 0.5mL 0.5mL 
Purified water 1.5mL 1.5mL 1.5mL 1.5mL 
Mix well and incubate at 370 C for 60 minutes 
Serum - - - 0.05mL 
Reagent 3 - 0.05mL - - 
Mix well and allow to stand at Room Temperature(15-300C) for 20 minutes 
Reagent 2 1.0mL 1.0mL 1.0mL 1.0mL 
Serum - - 0.05mL - 
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Procedure: 
 Direct Total 
Pipette into tube 
marked 
Sample blank (B1) Test (T1) Sample blank (B2) Test (T2) 
Reagent     
Reagent 1 - 50 - 50 mL 
Reagent 2 0.1mL 0.1mL 0.1mL 0.1mL 
Sample 0.1mL 0.1 mL 0.1mL 0.1mL 
Reagent 3 - - 1.0mL 1.0 mL 
Saline 1.0mL 1.0mL - - 
 
 
Mix and keep the assay mixture for 5 minutes of direct 
bilirubin and 10 minutes for Serum Bilirubin Read before 8 
minutes the absorbance of the test against their respective 
blanks at 540 nm (530 – 570 nm). 
Calculation: 
Bilirubin (Total or Direct)  
Mg (%) = (Abs Test - Abs Blank) × 20.2  
Estimation of Serum Total Protein (TP) & Albumin (ALB) 
Method using (Span diagnostics kit)  
Principle: Protein reacted with cupric ions in alkaline 
medium to from a violet colored complex. The intensity of 
the complex was measured at 530 nm against reagent blank 
0.01 mL of the standard solution, which was treated in the 
same way. 
Procedure for total protein: 
The reagents used were from span diagnostic kit.1 mL of 
working reagent was mixed with 0.01 mL of serum and 
absorbed at 530 nm. The reagent blank 0.01 mL of standard 
solution was treated in same way. Mix well after the addition 
of each reagents estimated with help of chemoanalyser and 
expressed as mg/ dl. 
Procedure for albumin: 
The reagents used were from span diagnostics kit and 
absorbed at 630nm. The reagent blank, 0.01 mL of standard 
solution was treated in same way. Mix well after the addition 
of each reagent Estimated with the help of chemoanalyser 
and expressed as mg/dl. 
Statistical Analysis: 
All the data are expressed as Mean ± S.E.M. One way analysis 
of variance (ANOVA) was used for the statistical analysis of 
data. Dunnett’s t comparison test was used for determining 
the significance. A probability value of p<0.05 was 
considered as significant. 
RESULT AND DISCUSSION 
Result 
Selection of Doses 
The doses were selected on the basis of acute toxicity study 
which is about 1/10 & 1/5 of maximum tolerated safe dose 
2000mg/kg i.e. 200 & 400 mg/kg for both extracts 
respectively. 
 
 
Hepatoprotective Activity of Extracts 
The hepatoprotective potential of ethanolic and aqueous 
extract of Callicarpa macrophylla leaves 
was evaluated against carbon tetrachloride (CCl4) induced 
acute hepatic injury in Wistar rats.Briefly, for the purpose, 
experimental rats of Group-I & II were administered with 
distilled water (5 mL/kg) and Group II served as a toxic 
control and treated with 1:1 (v/v) mixture of CCl4 in liquid 
paraffin (2 mL/kg, i.p) on 9th day whereas rats of Group-III 
received standard drug (Silymarin, 50 mg/kg), animals of 
test Group-IV & V received aqueous extract of Callicarpa 
macrophylla  leaves at dose of 200 & 400 mg/kg and animal 
of test Group VI & VII received ethanolic extract of Callicarpa 
macrophylla  leaves at dose of 200 & 400 mg/kg 
respectively. All treatments were given once daily by oral 
route, for nine days. Further, on ninth day of the study all 
rats of all groups except normal control group were 
administered with single intraperitoneal dose of CCl4 (2 
mL/kg) dissolved in liquid paraffin (1:1). Then on tenth day 
of the study (after 24 hours of CCl4 administration) blood 
samples were collected and analyzed for hepatic function 
biomarkers in serum.  
Carbon tetrachloride is well known toxic substance which is 
readily used to induce hepatic damage on experimental 
basis. As exhibited from Table 8,in carbon tetrachloride toxic 
control group, the SGOT, SGPT, ALP and serum bilirubin 
level, increase significantly, when compared to the normal 
control group confirming carbon tetrachloride liver toxicity. 
The oral pretreatment for 9 days with aqueous and ethanolic 
extract of Callicarpa macrophylla at dose of 200 & 400 
mg/kg results in significantly decrease (p <0.001, p < 0.01) 
in the level of SGOT, SGPT in the aqueous and ethanol extract 
of Callicarpa macrophylla  leaves against carbon 
tetrachloride control group.  
A significant reduction in the level of ALP (p<0.001, p< 0.01) 
was observed in the group treated with ethanolic and 
aqueous extract of Callicarpa macrophylla  leaves against 
carbon tetrachloride control group.The serum bilirubin level 
was decreased by aqueous and ethanol extract of Callicarpa 
macrophylla leaves shows significance (p <0.001, p < 0.01) 
against carbon tetrachloride control group. 
Also, there was statistically significant decrease in albumin 
and total protein in serum of experimental rats of CCl4and 
vehicle treated group whereas the animals of groups 
pretreated with Silymarin (50 mg/kg), ethanolic and 
aqueous extract (200 & 400 mg/kg, for both extract) when 
compared to that of normal control showed less reduction in 
serum albumin and total protein which is an indicative of 
hepatoprotective effect of Callicarpa macrophylla leaves 
extract.
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Table 2: Effect of Ethanolic and Aqueous extract of Callicarpa macrophylla leaves on liver function biomarkers in CCl4 induced 
hepatic injury in rats. 
Parameter SGOT (IU/L) SGPT (IU/L) ALP (IU/L) 
Serum 
Bilirubin 
(mg/dl) 
Serum 
Albumin   
(mg/dl) 
Total 
Protein 
(mg/dl) 
Control       (5 
mL/kg) 
64.31±2.67 51.25±4.63 173.53±1.87 0.41±0.03 6.37±0.45 7.25±0.12 
CCl4(2 mL/kg) 149.17±.4.35 127.35.± 5.21 347.63±7.27 1.71±0.04 4.15±0.31 3.51±0.09 
Silymarin 
(50mg/kg) 
70.35±3.41*** 51.45±3.61*** 181.93±2.31*** 0.51±0.02*** 5.17±0.03*** 7.01±0.11*** 
Ethanolic extract    
(200 mg/kg) 
113.25±2.3NS 105.13±3.61* 25.74±3.7* 0.85±0.01* 4.31±0.35* 5.61±0.03* 
Ethanolic extract    
(400 mg/kg) 
71.53±1.39*** 51.17±1.31*** 191.73±5.41*** 0.49±0.03** 5.05±0.03** 5.79±0.04** 
Aqueous extract    
(200 mg/kg) 
127.35±2.61* 
 
114.37±3.15NS 299.12±1.31NS 1.03±0.1NS 3.91±0.07* 4.37±0.02* 
Aqueous extract    
(400 mg/kg) 
86.31±1.52** 63.67±1.23** 215.41±4.21** 0.63±0.03** 4.51±0.13** 5.49±0.13*** 
Values are mean ± SEM, N = 6, Statistical analysis carried by ANNOVA followed by Dunnet “t” Test. NSp> 0.05, *p< 0.05, **p< 
0.01, ***p < 0.001. 
 
 
Figure 2: Effect of Silymarin, aqueous and ethanolic leaves extract of Callicarpamacrophylla treatment on SGOT, SGPT&ALP 
level in CCl4 induced hepatic injury in rats. (Columns represent MEAN ± SEM for n= 6/group). 
 
Figure 3: Effect of Silymarin, aqueous & ethanolic leaves extract of Callicarpa macrophylla treatment on STB level in CCl4 
induced hepatic injury in rats. (Columns represent MEAN ± SEM for n= 6/group). 
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Figure 4: Effect of Silymarin, aqueous & ethanolic extract of Callicarpa macrophylla treatment on serum albumin & total protein 
level in CCl4 hepatic injury in rats. (Columns represent MEAN ± SEM for n= 6/group). 
 
DISCUSSION 
The aqueous and ethanolic extract of the leaves Callicarpa 
macrophylla subjected for phytochemical study showed the 
presence of alkaloids, phenols, steroids, glycosides, 
phytosterols, fixed oil. The ethanolic and aqueous extract did 
not show any sign and symptoms of toxicity up to 2000 
mg/kg dose. The effect of oral pretreatment ethanolic and 
aqueous extract on SGOT, SGPT, ALP, total serum bilirubin, 
albumin and total protein were evaluated. 
CCl4 is a well-known hepatotoxic agent and the preventive 
action of liver damage by CCl4 has been widely used as an 
indicator of liver protective activity of drugs in general [24]. 
Hepatotoxicity induced by CCl4 is the most commonly used 
model system for the screening of hepatoprotective activity 
of plant extracts/drugs [25]. The changes associated with 
CCl4-induced liver damage are similar to that of acute viral 
hepatitis [19]. Toxicity begins with the changes in 
endoplasmic reticulum, which results in the loss of metabolic 
enzymes located in the intracellular structure. CCl4 is a 
xenobiotic that produces hepatotoxicity in various 
experimental animals. CCl4 is metabolized by cytochrome 
P450 to form a reactive trichloromethyl radical (CCl3) and a 
trichloromethyl peroxyl radical (CCl3O2). Both radicals are 
capable of binding to DNA, lipids, proteins or carbohydrates, 
leading to lipid peroxidation, cell necrosis, and excessive 
deposition of collagen in liver and liver fibrosis. 
The effect of CCl4 is generally observed after 24 h of its 
administration. Hence the withdrawal of the blood for 
biochemical parameters should be carried out only after 24 h 
of CCl4 intoxication. The total protein and albumin levels 
decreased due to the hepatotoxin intoxication. The reduction 
is attributed to the damage produced and localized in the 
endoplasmic reticulum which results in the loss of P450 
leading to its functional failure with a decrease in protein 
synthesis and accumulation of triglycerides. In the present 
study, CCl4 intoxication reduced the serum total protein and 
albumin levels. The pretreatment of WFM restored the total 
protein and albumin levels. The rise in protein and albumin 
level suggests the stabilization of endoplasmic reticulum 
leading to protein synthesis. 
In this study, significant increase in SGOT, SGPT, serum 
bilirubin and ALP levels in the serum was observed after 
administration of CCl4. The increased levels of SGOT, 
SGPT,serum bilirubin and ALP decreased by pretreatment 
with ethanolic and aqueous extracts of Callicarpa 
macrophylla leaves. Reduction in the levels of SGOT, SGPT, 
serum bilirubin and ALP towards the normal value is an 
indication of as repair of hepatic tissue damages caused by 
CCl4. 
The rise in marker enzymes level in CCl4 treated animals has 
been attributed to damaged structural integrity of the liver. 
Administration of the preserved this structural integrity of 
the hepatocellular membrane as evidenced from attenuation 
of the marker enzymes level when compared to CCl4 treated 
animals. It was further confirmed by the histopathological 
assessment of the liver tissue. Many studies have 
demonstrated that the hepatoprotective effect of plant 
extracts may be related to its antioxidant capacity to 
scavenge reactive oxygen species [26-28]. CCl4 intoxication 
reduced the total protein level in liver homogenate, which 
restored significantly with the pretreatment with ethanolic 
and aqueous extract (200 & 400 mg/kg, p.o) The possible 
hepatoprotective mechanism of Callicarpa macrophylla  
leavesextract against CCl4-induced liver injury may be 
through the following actions; inhibition of the cytochrome 
P-450 activity, prevention of the process of lipid 
peroxidation, stabilization of the hepatocellular membrane 
and enhancing the protein synthesis. The results indicate 
that the aqueous and ethanolic extract of Callicarpa 
macrophylla leaves has significant hepatoprotective activity. 
This may be probably due to the higher contents of 
flavonoids, flavones and flavan-3-ols. 
CONCLUSION 
The present study reports the hepatoprotective activity of 
Callicarpa macrophylla leaves extract on CCL4 induced 
hepatotoxicity in rats. Phytochemical screening revealed the 
presence of glycosides, flavonoids, alkaloids, phytosterols, 
saponins and phenolic compounds in the extracts. Several 
investigators have shown that flavonoids are mainly 
responsible for hepatoprotective potential in various 
experimental animal models. Thus, it can be interpreted that 
the significant hepatoprotective effect may be due to 
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presence of flavonoids.On the basis of results obtained it can 
be concluded that administration (200 mg/kg and 400 
mg/kg for both extract) of Callicarpa macrophylla leaves 
extract treated rats showed significant reduction of SGOT, 
SGPT, ALP, and bilirubin when compared with hepatotoxin 
treated rats, and the level of total protein and albumin were 
significantly increased.It can be concluded that the ethanolic 
extract of Callicarpa macrophylla leaves seems to have 
significant hepatoprotective activity in rats. The further 
studies are needed to evaluate potential usefulness of 
ethanolic and aqueous extract in clinical condition associated 
with liver damage. 
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